The F.D.A. is also reviewing the treatment, Albrioza, but the agency’s scientists have raised questions about its effectiveness.
![You are currently viewing New Experimental Therapy for A.L.S. Approved in Canada](https://globalbrokers.com/wp-content/uploads/2022/06/13ALS-01-moth-z698pR.jpeg)
New Experimental Therapy for A.L.S. Approved in Canada
- Post author:
- Post published:June 13, 2022
- Post category:News
- Post comments:0 Comments